Raimon Sabate

Av. Joan XXIII 27-31
Barcelona, CT 08028, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[h]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase Activity.

Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[h]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase Activity.

Journal: Biomolecules

Published: March 02, 2026

Rose Bengal-Incorporated Supramolecular Gels as a Topical Platform for Localized Antimicrobial Photodynamic Therapy.

Rose Bengal-Incorporated Supramolecular Gels as a Topical Platform for Localized Antimicrobial Photodynamic Therapy.

Journal: International journal of molecular sciences

Published: October 30, 2025

Design, Synthesis and Biological Evaluation of Chromeno[3,4-b]xanthones as Multifunctional Agents for Alzheimer's Disease.

Design, Synthesis and Biological Evaluation of Chromeno[3,4-b]xanthones as Multifunctional Agents for Alzheimer's Disease.

Journal: ACS chemical neuroscience

Published: August 06, 2025

YAT2150: Overcoming limitations of traditional amyloid dyes in aggregation studies.

YAT2150: Overcoming limitations of traditional amyloid dyes in aggregation studies.

Journal: Bioorganic & medicinal chemistry

Published: December 31, 2024

Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties.

Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties.

Journal: Pharmaceutics

Published: June 26, 2024

In Vivo Assays for Amyloid-Related Diseases.

In Vivo Assays for Amyloid-Related Diseases.

Journal: Annual review of analytical chemistry (Palo Alto, Calif.)

Published: April 10, 2024

Proximity-Induced Pharmacology for Amyloid-Related Diseases.

Proximity-Induced Pharmacology for Amyloid-Related Diseases.

Journal: Cells

Published: January 30, 2024

Probing Alzheimer's pathology: Exploring the next generation of FDDNP analogues for amyloid β detection.

Probing Alzheimer's pathology: Exploring the next generation of FDDNP analogues for amyloid β detection.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 19, 2024

Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics.

Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics.

Journal: Neural regeneration research

Published: October 20, 2023

Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.

Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: July 28, 2023

Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer's disease.

Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer's disease.

Journal: Bioorganic & medicinal chemistry

Published: April 06, 2023

New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease.

New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 11, 2023

Showing 1-12 of 75

Last Updated: 09/26/2026